2018
DOI: 10.1097/md.0000000000011617
|View full text |Cite
|
Sign up to set email alerts
|

Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction (STEMI)

Abstract: Acute myocardial infarction (AMI) is recognized as being a life-threatening event. Both microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH) have been recognized as poor prognostic factors in myocardial infarct (MI) since they adversely affect left ventricular remodeling. MVO refers to small vessels changes that prevent adequate tissue perfusion despite revascularization whereas IMH is a severe form of MVO. A limited number of studies have demonstrated the segmental intervention time and the cl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
3
7

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(26 citation statements)
references
References 31 publications
0
7
3
7
Order By: Relevance
“…CMR is uniquely suited to provide important mechanistic and pathophysiological information on infarct size, MVO, and intramyocardial hemorrhage. [3,4] To the authors’ knowledge, this is the first post-hoc analysis of randomized study to evaluate the impact of postprocedural anticoagulation on infarct size, LVEF, and LV remodeling in patients with STEMI undergoing primary PCI by using CMR and 2D-echocardiography. However, several limitations of the study should be emphasized.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CMR is uniquely suited to provide important mechanistic and pathophysiological information on infarct size, MVO, and intramyocardial hemorrhage. [3,4] To the authors’ knowledge, this is the first post-hoc analysis of randomized study to evaluate the impact of postprocedural anticoagulation on infarct size, LVEF, and LV remodeling in patients with STEMI undergoing primary PCI by using CMR and 2D-echocardiography. However, several limitations of the study should be emphasized.…”
Section: Discussionmentioning
confidence: 99%
“…These additional assessed parameters, primarily microvascular obstruction (MVO), but also myocardial infarct sizing provide strong prognostic information that is incremental to clinical, biomarker, electrocardiographic, and angiographic risk markers. [3,4] LVEF is the classical surrogate functional parameter, because it has been clearly associated with long-term morbidity and mortality after STEMI. [5] In addition, postinfarction LV remodeling has been usually reported to have an impaired prognosis, more often developing into clinical heart failure and resulting in increased mortality.…”
Section: Introductionmentioning
confidence: 99%
“…Если МВО относится к общепризнанным предикторам патологического ремоделирования и прогрессирования сердечной недостаточности, то мнения о ГПМ противоречивы [5][6][7][8][9]. Согласно метаанализу, включающему 9 исследований, возникновение ГПМ рассматривается как прогностически более неблагоприятный фактор, который ассоциирован со снижением сократительной функции и патологическим ремоделированием миокарда.…”
Section: Effect Of Intramyocardial Haemorrhage On Structural and Funcunclassified
“…распространенность ГПМ составила 50%, а МВО была визуализирована в 66% случаев [4]. При этом описана взаимосвязь наличия МВО и ГПМ [2][3][4]12]. По нашим данным, сочетание МВО и ГПМ встречалось часто -в 29,8% случаев, однако различия между группами не были статистически значимыми.…”
Section: рис 4 значения кардиоспецифических ферментов (кфк кфк-мвunclassified
“…Проведенные исследования продемонстрировали, что реперфузионная терапия способна приводить к эффекту, совершенно противоположному ожидаемому, вызывая развитие реперфузионно/ишемического повреждения [2]. Одним из значимых компонентов реперфузионной травмы является поражение микроциркуляторного русла, состоящего из двух феноменов: микроваскулярной обструкции (МВО), также известной как феномен no-reflow, и геморрагического пропитывания миокарда (ГПМ) [3][4][5].…”
unclassified